Precore and core promoter mutants are associated with higher HBeAg seroconversion but low disease remission rates in HBV patients treated with nucleos(t)ide analogues

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)322-327
Number of pages6
JournalJournal of Viral Hepatitis
Volume20
Issue number5
DOIs
Publication statusPublished - 2013

Cite this